| Identification | Back Directory | [Name]
BN 50730 | [CAS]
132579-32-9 | [Synonyms]
LAU8080
LAU-8080
LAU 8080
BN 50730
PubChem ID: 3033963
6-(2-Chlorophenyl)-9-((4-methoxyphenyl)thiocarbamoyl)-1-methyl-7,8,9,10-tetrahydro-4H-pyrido(4',3'-4,5)thieno(3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine
4H-Pyrido(4',3'-4,5)thieno(3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine-9(8H)-carbothioamide, 6-(2-chlorophenyl)-7,10-dihydro-N-(4-methoxyphenyl)-1-methyl- | [Molecular Formula]
C26H23ClN6OS2 | [MDL Number]
MFCD00867800 | [MOL File]
132579-32-9.mol | [Molecular Weight]
535.08 |
| Hazard Information | Back Directory | [Description]
Rocepafant, also known as BN-50730; LAU-8080, is a platelet activating factor (PAF) antagonist potentially for the treatment of asthma. BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. BN 50730 also showed activity to inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells. |
|
|